Search Within

Solid Tumor Oncology Division

Formats
  1. Journal Article (11004)
  2. Meeting Abstract (9530)
  3. Review (575)
  4. Book Section (417)
  5. Editorial (341)
  6. Guidelines (161)
  7. Correspondence (120)
  8. Conference Paper (107)
  9. Research Letter (63)
  10. Miscellaneous (55)
  11. Book Whole (27)
Groups
  1. Department of Medicine (22376)
  2. GSK Faculty (5953)
  3. Genitourinary Oncology Service (5684)
  4. Survivorship Research (5261)
  5. Gastrointestinal Oncology Service (4738)
  6. Breast Medicine Service (4179)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. Clifford Hudis (906)
  4. Jedd Wolchok (905)
  5. Mark Kris (873)
  6. Eileen O'Reilly (800)

More People

Years
  1. 2025 (776)
  2. 2024 (1389)
  3. 2023 (1381)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1536)

More Years

Publications
  1. Journal of Clinical Oncology (5297)
  2. Annals of Oncology (1309)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (781)
  5. Journal of Thoracic Oncology (534)
  6. Gynecologic Oncology (443)

More Publications

Publishers
  1. American Society of Clinical Oncology (5592)
  2. American Association for Cancer Research (2332)
  3. Elsevier Inc. (2239)
  4. Oxford University Press (1838)
  5. Nature Publishing Group (1053)
  6. Springer (992)

More Publishers

Results (22400)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Office-based flexible sigmoidoscopy allows rapid assessment and management of suspected immune checkpoint inhibitor-related colitis
    Journal Article

    Siev, A.; Livingstone, P.; Tom, E.; Corso, T.; Preeshagul, I.; Postow, M.; Shah, N. J.; Niec, R.; Schattner, M.; Faleck, D. M.
    Annals of Gastroenterology (2025)

    Fulltext@MSK | Save
  • Adjuvant systemic therapy in melanoma: Relative versus absolute benefit; The number needed to treat (NNT) versus the number needed to harm (NNH)?
    Review

    van Akkooi, A. C. J.; Mandala, M.; Nathan, P.; Haydon, A.; Postow, M.; Rutkowski, P.
    EJC Skin Cancer (2025)

    Fulltext@MSK | Save
  • Multi-modality AI predictor of lung cancer immunotherapy treatment response of durable response (DR)
    Meeting Abstract

    Jiang, J.; Yu, H.; Gomez, D.; Veeraraghavan, H.
    Radiotherapy and Oncology (2025)

    Fulltext@MSK | Save
  • An advanced practice provider-led telehealth intervention for oncology patients at end-of-life
    Meeting Abstract

    Lauria, T.; Qualters, K.; Kapoor-Hintzen, N.; Rosa, W.; Epstein, A.; Levine, M.; Koo, D.; Egan, B.; Puccia, S.; Gandham, A.; more...
    Journal of Pain and Symptom Management (2025)

    Fulltext@MSK | Save
  • Integration of health-related values in oncology as a primary palliative care intervention
    Meeting Abstract

    Rosa, W.; Epstein, A.; Goldberg, J.; Cohen, A.; Rosen, R.; Desai, A.; Gilliland, J.; Nelson, J.
    Journal of Pain and Symptom Management (2025)

    Fulltext@MSK | Save
  • Phase 2 dose expansion of START-001: A phase 1/2 study of invikafusp alfa (STAR0602), a first-in-class, selective T cell receptor (TCR)-targeting, bifunctional antibody-fusion molecule, as monotherapy in patients with antigen-rich tumors resistant to anti-PD(L)-1
    Meeting Abstract

    Friedman, C. F.; Sullivan, R. J.; Tschernia, N.; Sonpavde, G. P.; Herrera, M.; He, K.; Bilusic, M.; Garralda, E.; Hernando-Calvo, A. H.; Silk, A. W.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 1, first-in-human study of CTIM-76, a claudin-6 (CLDN6)-directed bispecific antibody, in patients with recurrent ovarian cancer and other advanced solid tumors
    Meeting Abstract

    O'Cearbhaill, R. E.; Barve, M. A.; Darus, C.; Gabrail, N. Y.; Johannet, P.; Loh, J.; Lerose, M.; Andreas, K.; Ullmann, C. D.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase I study of AFNT-211, autologous CD4(+) and CD8(+) T cells engineered to express a high avidity HLA-A(*)11:01-restricted, KRAS G12V-specific transgenic TCR; CD8α/β coreceptor; and FAS-41BB switch receptor in patients with advanced or metastatic solid tumors
    Meeting Abstract

    Basu, S. K.; Khan, B.; Payumo, F.; Wan, R.; Chiorean, E. G.; Gahvari, Z.; Hecht, J. R.; Hurwitz, M. E.; Leidner, R. S.; Lenz, H. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase 1, first-in-human study of DS-2243, an HLA-A(*)02/NY-ESO-directed bispecific T-cell engager, in patients with advanced solid tumors
    Meeting Abstract

    D'Angelo, S. P.; Subbiah, V.; Blay, J. Y.; Wagner, M. J.; Steeghs, N.; Youk, J.; Mizusako, H.; Ohue, Y.; Jin, J.; Rajper, A. W.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Body mass index and somatic variants in biliary tract cancers
    Meeting Abstract

    Al Mahmasani, L.; Chou, J. F.; Capanu, M.; Srivastava, A.; Sigel, C. S.; Alsuwailem, R.; Berger, M. F.; Khalil, D. N.; Harding, J. J.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save